- Report
- August 2022
- 120 Pages
Global
From €4157EUR$4,750USD£3,614GBP
- Report
- May 2024
- 130 Pages
Global
From €3500EUR$3,999USD£3,042GBP
- Report
- May 2024
- 129 Pages
Global
From €3500EUR$3,999USD£3,042GBP
- Report
- May 2024
- 138 Pages
Global
From €3500EUR$3,999USD£3,042GBP
- Report
- December 2024
- 200 Pages
Global
From €3282EUR$3,750USD£2,853GBP
- Report
- May 2024
- 200 Pages
Global
From €3632EUR$4,150USD£3,157GBP
- Report
- May 2024
- 200 Pages
Global
From €3632EUR$4,150USD£3,157GBP
- Report
- May 2024
- 200 Pages
Global
From €3632EUR$4,150USD£3,157GBP
- Report
- May 2024
- 200 Pages
Global
From €3632EUR$4,150USD£3,157GBP
- Report
- May 2024
- 200 Pages
Global
From €3632EUR$4,150USD£3,157GBP
- Report
- March 2024
- 200 Pages
Global
From €3632EUR$4,150USD£3,157GBP
- Report
- August 2023
- 145 Pages
Global
From €2757EUR$3,150USD£2,396GBP
- Report
- July 2024
- 150 Pages
Global
From €3282EUR$3,750USD£2,853GBP
- Report
- July 2024
- 150 Pages
Global
From €3282EUR$3,750USD£2,853GBP
- Report
- June 2024
- 200 Pages
Global
From €6958EUR$7,950USD£6,048GBP
- Report
- May 2023
- 450 Pages
Global
From €4376EUR$5,000USD£3,804GBP
- Report
- July 2024
- 120 Pages
Global
From €4157EUR$4,750USD£3,614GBP
- Report
- February 2024
- 131 Pages
Global
From €4157EUR$4,750USD£3,614GBP
- Report
- April 2023
- 111 Pages
Global
From €4157EUR$4,750USD£3,614GBP
- Report
- October 2022
- 113 Pages
Global
From €4157EUR$4,750USD£3,614GBP

T Cell Therapies are a type of biotechnology that involves the use of a patient's own T cells to treat diseases. T cells are a type of white blood cell that play a key role in the body's immune system. T Cell Therapies involve the extraction of T cells from a patient, engineering them to recognize and attack specific targets, and then reintroducing them into the patient's body. This type of therapy has been used to treat a variety of cancers, including leukemia, lymphoma, and multiple myeloma. It has also been used to treat autoimmune diseases, such as rheumatoid arthritis and Crohn's disease.
T Cell Therapies are a rapidly growing field of biotechnology, with many companies investing in research and development. Companies such as Kite Pharma, Juno Therapeutics, and Novartis are leading the way in developing and commercializing T Cell Therapies. Other companies, such as Gilead Sciences, Celgene, and Regeneron, are also investing in the field. Show Less Read more